← Evidence map

ReviewBMC urology2023

Active surveillance should be considered for select men with Grade Group 2 prostate cancer.

Kelly R Pekala et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

10 papers cite it

2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 37777716